| Website | nanomr.com |
| Phone | 505-924-6300 |
| Employees |
| TOTAL | $13M |
| VENTURE FUNDING TOTAL | $13M |
| Series B, 7/11 Excel Venture Management HealthCare Ventures vSpring Capital Sun Mountain Capital | $13M |
nanoMR has developed the first system for rapid isolation of rare cells from complex matrices at levels of 1 cell/mL or lower. The immunomagnetic capture system can target multiple cell types simultaneously, for example capturing bacteria and fungi from bloodstream infections, or specific cell types, such as circulating tumor, or fetal, cells, in less than 30 minutes.
